SuRo Capital Corp. operates as a publicly traded investment fund. It seeks to invest in a broad range of sectors and industries as well as to provide investors with access to such companies through its publicly traded common stock. The company was founded by Mark David Klein on September 17, 2010 and is headquartered in New York, NY.
Subscribe to see Neostellar Capital Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Neostellar Capital Corp. is an asset management company headquartered in San Francisco, United States. It is publicly listed (NSLR) with a market capitalisation of $180.3M. Xcout tracks 13 named people at Neostellar Capital Corp., including Mark David Klein (Chairman, President & CEO).
7 more named people on record for Neostellar Capital Corp., with roles, board committees and tenure — see the full roster →
A few of Neostellar Capital Corp.'s closest competitors — see the full list of competitors and alternatives →
Spectral Capital Corporation is an emerging enterprise focused on identifying, acquiring, developing, and financing innovative technologies capable of transforming various industries within the United States. Its endeavors include the procurement and advancement of information technology, such as providing personalized search engine solutions for mobile devices. The company also furnishes web-based applications and services that enable users to effortlessly discover, consume, analyze, share, and discuss financial news, market insights, equities, commodities, and currencies. Additionally, Spectral Capital offers specialized technology and financial data services, employing its proprietary software to identify and present currently appreciating stocks to professional trading organizations. Established in 2000, Spectral Capital Corporation is headquartered in Seattle, Washington.
CM Life Sciences II Inc. currently conducts no substantial business operations. Its primary goal is to complete a strategic business combination, which could involve a merger, stock or asset acquisition, or reorganization, with one or more enterprises within the life sciences field. The company was founded in 2020 and has its headquarters in New York City.
Torrent Capital Ltd. is a publicly traded investment company that provides capital to growth-oriented businesses across various sectors and asset classes. The firm invests in public equities, private ventures, and royalty projects, targeting industries such as technology, cleantech, and digital assets.
Brompton Energy Split Corp. is a closed-end mutual fund. Its investment objective is to provide holders of preferred shares with fixed, cumulative, preferential quarterly cash distributions, and holders of class A shares with regular monthly cash distributions through investing in a common share portfolio. The company was founded on December 30, 2014 and is headquartered in Toronto, Canada.
Source Capital, Inc., known by its ticker SOR, is a closed-end, balanced investment fund under the management of First Pacific Advisors, LLC. Its investment mandate primarily targets the public equity markets within the United States, aiming to allocate capital across a broad spectrum of industry sectors. A core tenet of its strategy involves identifying value-oriented equities, specifically within the small and mid-capitalization segments. The construction of its portfolio is driven by a meticulous, bottom-up fundamental analysis. This involves a rigorous screening process that prioritizes companies exhibiting robust liquidity, conservative balance sheets (characterized by low leverage), and a proven long-term capacity to generate superior returns on invested capital. Source Capital's performance is gauged against a trio of prominent market benchmarks: the Russell 2500 Index, the S&P 500 Index, and the Nasdaq Composite Index. The fund itself was established on June 1, 1968, and operates from its base in the United States.
Currently, Perceptive Capital Solutions Corp possesses no significant active operations. Its principal objective is to execute a strategic business combination—such as a merger, share swap, asset procurement, equity acquisition, or corporate restructuring—with one or more enterprises or entities engaged in the life sciences and medical technology sectors. These prospective partners are sought exclusively within North America or Europe. The company was established in 2024, with its corporate base located in New York, New York.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Neostellar Capital Corp.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.